Literature DB >> 27478582

A Rare Association of Hepatitis A Virus Infection with Type-1 Diabetes.

Mohammed Hasosah1, Alaa Bokhari2, Ashraf Alsahafi1, Ghassan Sukkar1, Abdullah Alzaben3.   

Abstract

Patients with type-1 diabetes are predisposed to develop a spectrum of liver diseases, which includes fatty liver, steatohepatitis and cirrhosis. The association of hepatitis A infection with type-1 diabetes is extremely rare. To the best of our knowledge, our case is the first case report in children. We described a nine year-old girl who had type-1 diabetes and developed hepatitis A virus infection without complications. A review of the literature is also provided.

Entities:  

Keywords:  Hepatitis A virus; type-1 diabetes

Year:  2016        PMID: 27478582      PMCID: PMC4943102          DOI: 10.4081/cp.2016.844

Source DB:  PubMed          Journal:  Clin Pract        ISSN: 2039-7275


Introduction

Hepatitis A virus (HAV) occurs throughout the world, and humans are thought to be its principal host.[1] Type-1 diabetes is a disorder of glucose metabolism that results from insulin deficiency secondary to autoimmune destruction of insulin-secreting β-cells. Although the pathogenesis of type-1 diabetes is unknown, human leukocyte antigen typing, viral infections and T-cell autoimmunity may be involved.[2] The prevalence of liver disease among diabetics is estimated to be between 17 and 100%.[3] The present paper describes a 9- year-old girl who has type-1 diabetes and presented HAV infection. Both diseases are rare association. A review of the literature is also provided

Case Report

A 9-year-old girl presented with vomiting and abdominal pain for three days. She describes vomiting is non-bilious, non-bloody and it is food content. It is associated with generalized mild abdominal pain with no relieving or precipitating factors. There was history of jaundice, diarrhea and poor appetite. No history of fever, skin rash, joint pain or recent travel. She had a known history of type-1 diabetes diagnosed at age 5. The family revealed no history of liver disease. The patient had normal developmental milestones. She was taking insulin medications. Physical examination revealed yellowish discoloration of eyes and skin but no evidence of growth retardation. Abdominal examination revealed tender hepatomegaly but no splenomegaly or ascites. Other systemic examination was otherwise unremarkable. The laboratory findings revealed normal hemoglobin, white blood cell, and platelet counts. Other investigations are summarized in Table 1. Abdominal ultrasound showed multiple hyper echoic foci with mild ascites, gallbladder wall was thickened with pericholecystic fluids.
Table 1.

Laboratory results.

ResultNormal range
Total bilirubin152.2 μmol/L2.1-15.5 μmol/L
Direct bilirubin101 μmol/L0.0-9.0 μmol/L
AST1333 U/L10-23 U/L
ALT1573 U/L6-28 U/L
Albumin33 g/L38-54 g/L
ALK969 IU/L1-500 IU/L
GTT497 IU/L7-30 IU/L
INR0.90.8-1.2
Serum glucose9.1 mmol/L3.3-5.6 mmol/L
Urine ketones+++–ve
HgbA1C10.4%3.9-6.1%
Amylase18 U/L25-125 U/L
Hepatitis A IgM+ve (reactive)–ve
Hepatitis A IgG+ve–ve
CMV PCR–ve–ve
HSV PCR–ve–ve
EBV IgM–ve–ve
HBsAg–ve–ve
HC Ab–ve–ve
Anti liver kidney microsomal Ab–ve–ve
Anti mitochondrial Ab–ve–ve
Anti-smooth Ab–ve–ve

ALT, alanine transaminase; AST, aspartate aminotransferase; ALK, alkaline phosphatase; GGT, gammaglutamyltransferase; INR, international normalized ratio; HBsAg, hepatitis B surface antigen; HC Ab, hepatitis C antibody; CMV PCR, cytomegalovirus polymerase chain reaction; HSV PCR, herpes simplex virus polymerase chain reaction; EBV IgM, Epstein-Barr virus immunoglobulin M; –ve, negative; +ve, positive.

A diagnosis of acute HAV infection was made and the child was managed with diabetes protocol. At 3 months follow up from the onset of disease, she was completely asymptomatic, hepatitis A immunoglobulin M became negative and other laboratory investigations normalized.

Discussion

Patients with type-1 diabetes are predisposed to develop a spectrum of liver diseases which includes fatty liver, steatohepatitis, cirrhosis, hepatic failure and hepatocellular carcinoma.[4] The association of HAV Infection with type-1 diabetes have been described in adult.[5-8] To the best of our knowledge, our case is the first case report in a children. Although the pathogenesis of type-1 diabetes is unknown, viral infections may or may not be involved. Kondrashova and colleagues,[9] demonstrated a possible protective effect of microbes in animal models, where HAV has associated with low risk of type-1 diabetes. Another study showed that hepatitis virus infection (HAV, HBV, HCV and HEV) were not associated with type-1 diabetes.[6] In contrast, patients with diabetes are at risk to contact viral hepatitis infection. Singh and colleagues documented that patients with diabetes mellitus are at high risk to develop severe hepatitis as well as liver failure subsequent to acute viral infection mainly hepatitis B virus but HAV was not involved.[10] Makken and colleagues[8] showed that three patients with diabetic ketoacidosis have been reported within 2-3 weeks of acute hepatitis A, although the C-peptide levels were not measured. Hwang and colleagues[5] reported an adult man who presented with fulminant type-1 diabetes and acute HAV. Our child did not develop complications of diabetes, and HAV recovered spontaneously. We believe that the immune system in the child may play a role in good prognosis of diabetes and HAV. Ertem and colleagues[11] reported HAV is associated with immune-associated diseases, including autoimmune hepatitis, immune thrombocytopenic purpura, cryoglobulinaemia and vasculitis. The data of Ertem and colleagues[11] taken together with the observation in our patient suggest that HAV is associated with immune-associated diseases such as type-1 diabetes.

Conclusions

We described a girl who had type-1 diabetes and developed HAV infection without complications. We found that HAV could be associated with immune-associated diseases such as type-1 diabetes. However, the mechanism of hepatitis A virus-induced B-cell destruction is unknown. This case report emphasizes the need for more research to help in understanding the association of type-1 diabetes with HAV infection.
  11 in total

1.  Fulminant Type 1 diabetes mellitus associated with acute hepatitis A.

Authors:  Y-C Hwang; I-K Jeong; S Chon; S Oh; K J Ahn; H Y Chung; J-T Woo; S-W Kim; J-W Kim; Y S Kim
Journal:  Diabet Med       Date:  2010-03       Impact factor: 4.359

Review 2.  Hepatitis A virus: from discovery to vaccines.

Authors:  Annette Martin; Stanley M Lemon
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 3.  The association of infective hepatitis type A (HAV) and diabetes mellitus.

Authors:  A M Makeen
Journal:  Trop Geogr Med       Date:  1992-10

4.  Patients with Diabetes Mellitus are Prone to Develop Severe Hepatitis and Liver Failure due to Hepatitis Virus Infection.

Authors:  Kumar K Singh; Subrat K Panda; Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-11-23

Review 5.  Liver diseases and diabetes mellitus.

Authors:  W Creutzfeldt; H Frerichs; K Sickinger
Journal:  Prog Liver Dis       Date:  1970

Review 6.  Role of viruses and other microbes in the pathogenesis of type 1 diabetes.

Authors:  Anita Kondrashova; Heikki Hyöty
Journal:  Int Rev Immunol       Date:  2014-03-10       Impact factor: 5.311

7.  Autoimmune complications associated with hepatitis A virus infection in children.

Authors:  D Ertem; Y Acar; E Pehlivanoglu
Journal:  Pediatr Infect Dis J       Date:  2001-08       Impact factor: 2.129

Review 8.  Hepatitis A-induced diabetes mellitus, acute renal failure, and liver failure.

Authors:  D L Vesely; R W Dilley; W C Duckworth; F F Paustian
Journal:  Am J Med Sci       Date:  1999-06       Impact factor: 2.378

Review 9.  The intestinal and liver complications of diabetes mellitus.

Authors:  K R Falchuk; D Conlin
Journal:  Adv Intern Med       Date:  1993

10.  Prevalence of hepatitis A, B, C and E virus in adolescents with type-1 diabetes mellitus.

Authors:  Mehmet Emre Atabek; Hulya Kart; Ibrahim Erkul
Journal:  Int J Adolesc Med Health       Date:  2003 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.